InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-36.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Bohlin Garen G, Director. Insider active across 3 companies, notably Collegium Pharmaceutical, INC. Cumulatively, 9 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €72k. Activity tracked since 6 May 2021. The latest transaction was disclosed on 21 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Bohlin Garen G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
15,508 shares0Common StockSEC:0001254705-26-000008:0
8,700 shares@ US$16.490.0083% mcap100.0% of flowCommon StockSEC:0001254705-26-000002:0
9,791 shares0Common StockSEC:0001062993-25-009808:0
28,985 shares@ US$5.7355.8% of flowCommon StockSEC:0001062993-24-010536:0
41,140 shares@ US$1.21547.3% of flowCommon StockSEC:0000950170-23-047712:0
Canonical exit: 11 Dec 2023 (T+90)
9,792 shares0Common StockSEC:0001062993-23-011813:0
14,035 shares0Common StockSEC:0001062993-22-013300:0
9,941 shares0Common StockSEC:0001192482-21-000453:0
4,000 shares@ US$7.8235.8% of flowCommon StockSEC:0001209191-21-031437:0
Canonical exit: 4 Aug 2021 (T+90)
9 of 9 declarations
About Bohlin Garen G
BOHLIN GAREN G is a Board Member at COLLEGIUM PHARMACEUTICAL, INC and Karyopharm Therapeutics Inc. He contributes to the governance and strategy of the companies, bringing his expertise in leadership and decision-making.
